Skip to main content
. 2019 Nov 8;20(1):1030. doi: 10.4102/sajhivmed.v20i1.1030

TABLE 3.

Summary of recommendation 3.

Phase Duration Treatment
Induction 2 weeks
  • Preferred regimen: 1 week of amphotericin B deoxycholate (1 mg/kg/day) and flucytosine (100 mg/kg/day divided into four doses per day), followed by 1 week of fluconazole (1200 mg daily for adults; 12 mg/kg/day for children and adolescents up to a maximum of 800 mg daily)

  • Alternative options

  • 2 weeks of fluconazole (1200 mg daily for adults; 12 mg/kg/day for children and adolescents) and flucytosine (100 mg/kg/day divided into four doses per day)

  • Preferred option if flucytosine is unavailable: 2 weeks of amphotericin B deoxycholate (1 mg/kg/day) and fluconazole (1200 mg daily for adults, 12 mg/kg/day for children and adolescents)

  • If liposomal amphotericin B is available for patients with renal dysfunction: 1 week of liposomal amphotericin B (3 mg/kg/day – 4 mg/kg/day) and flucytosine (100 mg/kg/day divided into four doses per day), followed by 1 week of fluconazole (both fluconazole and flucytosine doses adjusted for renal impairment)

Consolidation 8 weeks Fluconazole (800 mg daily for adults; 12 mg/kg/day for children and adolescents up to a maximum of 800 mg daily)
Maintenance Continue for at least 12 months until a single CD4 count > 200 cells/µL and a suppressed HIV viral load Fluconazole (200 mg daily for adults; 6 mg/kg/day for children and adolescents up to a maximum of 200 mg daily)